Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy
GHDx Entry last modified on: Mar 3, 2019
Antiretroviral therapy
Dataset Records for Antiretroviral therapy
Displaying 801 - 850 of 903
CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression
GHDx Entry last modified on: Mar 3, 2019
Long-term antiretroviral treatment outcomes in seven countries in the Caribbean
GHDx Entry last modified on: Mar 3, 2019
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies
GHDx Entry last modified on: Mar 3, 2019
Increase and plateau of CD4 T-cell counts in the 3(1/2) years after initiation of potent antiretroviral therapy
GHDx Entry last modified on: Mar 3, 2019
Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function
GHDx Entry last modified on: Mar 3, 2019
Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV
GHDx Entry last modified on: Apr 10, 2023
Indonesia - Gorontalo Province Health Profile 2016
Profil Kesehatan Provinsi Gorontalo Tahun 2016
Report:
Epi surveillance
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies
GHDx Entry last modified on: Mar 3, 2019
When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience
GHDx Entry last modified on: Mar 3, 2019
Effect of baseline CD4 cell count at linkage to HIV care and at initiation of antiretroviral therapy on mortality in HIV-positive adult patients in Rwanda: a nationwide cohort study
GHDx Entry last modified on: Mar 3, 2019
Effect of Sex and Age on Outcomes among Hiv-2 Infected Patients Starting Antiretroviral Therapy in West Africa: a Multicentre Cohort Study
GHDx Entry last modified on: Jul 20, 2021
Restoration of normal interleukin-2 production by CD4+ T cells of human immunodeficiency virus-infected patients after 9 months of highly active antiretroviral therapy
GHDx Entry last modified on: Mar 3, 2019
Long-term patterns in CD4 response is determined by an interaction between baseline CD4 cell count, viral load and time: the Asia Pacific HIV Observational Database (APHOD)
GHDx Entry last modified on: Mar 3, 2019
Guinea-Bissau Multiple Indicator Cluster Survey 1996
Inquérito aos Indicadores Múltiplos 1996
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative - Subnationally representative
Efficient human immunodeficiency virus ( HIV)-1 Gag-Env pseudovirion formation elicited from mammalian cells by a canarypox HIV vaccine candidate
GHDx Entry last modified on: Mar 3, 2019
Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries
GHDx Entry last modified on: Mar 3, 2019
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals
GHDx Entry last modified on: Mar 3, 2019
Zambia Annual Health Statistical Bulletin 2011
Report:
Epi surveillance - Inpatient - Outpatient - Subnationally representative
A cost-effectiveness analysis of HIV preexposure prophylaxis for men who have sex with men in Australia
GHDx Entry last modified on: May 20, 2024
Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults
GHDx Entry last modified on: Mar 3, 2019
Zambia Annual Health Statistical Bulletin 2012
Republic of Zambia Annual Health Statistical Bulletin 2012
Report:
Epi surveillance - Inpatient - Outpatient - Subnationally representative
Oman Annual Health Report 2017
Report:
Discharge - Epi surveillance - Inpatient - Nationally representative - Outpatient - Subnationally representative
Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2
GHDx Entry last modified on: Mar 3, 2019
Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care
GHDx Entry last modified on: Mar 3, 2019
The safety and efficacy of granulocyte-macrophage colony-stimulating factor (Sargramostim) added to indinavir- or ritonavir-based antiretroviral therapy: a randomized double-blind, placebo-controlled trial
GHDx Entry last modified on: Oct 9, 2019
Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean
GHDx Entry last modified on: Mar 3, 2019
Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy
GHDx Entry last modified on: Mar 3, 2019
Inequalities by educational level in response to combination antiretroviral treatment and survival in HIV-positive men and women in Europe
GHDx Entry last modified on: Jan 12, 2024
Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies
GHDx Entry last modified on: Mar 3, 2019
Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression
GHDx Entry last modified on: Mar 3, 2019
Polyspecific self-reactive antibodies in individuals infected with human immunodeficiency virus facilitate T cell deletion and inhibit costimulatory accessory cell function
GHDx Entry last modified on: Mar 3, 2019
Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality
GHDx Entry last modified on: Mar 3, 2019
Chemokine receptor polymorphisms and human immunodeficiency virus disease progression
GHDx Entry last modified on: Mar 3, 2019
Rwanda Annual Health Statistics Booklet 2014
Report:
Discharge - Epi surveillance - Financial - Inpatient - Nationally representative - Outpatient - Subnationally representative
World Health Statistics Report 2005
GHDx Entry last modified on: Nov 6, 2018
Low effectiveness of highly active antiretroviral therapy and high mortality in the Greenland HIV-infected population
GHDx Entry last modified on: Mar 3, 2019
Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease
GHDx Entry last modified on: Mar 3, 2019
Effect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals
GHDx Entry last modified on: Mar 3, 2019
Indonesia - Sumatera Selatan Province Health Profile 2017
Profil Kesehatan Provinsi Sumatera Selatan Tahun 2017
Report:
Epi surveillance
Low mortality in HIV-infected patients starting highly active antiretroviral therapy: a comparison with the general population
GHDx Entry last modified on: Mar 3, 2019
Indonesia - Sumatera Selatan Province Health Profile 2012
Profil Kesehatan Provinsi Sumatera Selatan Tahun 2012
Report:
Epi surveillance
Bhutan Annual Health Bulletin 2016
ལོ་བསྟར་གསོ་བའི་གནས་དེབ། ༢༠༡༦
Report:
Epi surveillance - Inpatient - Outpatient - Subnationally representative
Indonesia - Kalimantan Barat Province Health Profile 2016
Profil Kesehatan Provinsi Kalimantan Barat Tahun 2016
Report:
Epi surveillance
Virologic, immunologic, and clinical response to highly active antiretroviral therapy: the gender issue revisited
GHDx Entry last modified on: Oct 24, 2024
Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection
GHDx Entry last modified on: Mar 3, 2019
Indonesia - Kalimantan Barat Province Health Profile 2014
Profil Kesehatan Provinsi Kalimantan Barat Tahun 2014
Report:
Epi surveillance
Indonesia - Kalimantan Barat Province Health Profile 2015
Profil Kesehatan Provinsi Kalimantan Barat Tahun 2015
Report:
Epi surveillance
Brief report: effectiveness of combination antiretroviral therapy on survival and opportunistic infections in a developing world setting: an observational cohort study
GHDx Entry last modified on: Mar 3, 2019
Myanmar National Tuberculosis Programme Annual Report 2016
Report:
Epi surveillance - Operational - Organization - Subnationally representative
Subscribe